Log in to save to my catalogue

Impact of rewarming rate on interleukin-6 levels in patients with shockable cardiac arrest receiving...

Impact of rewarming rate on interleukin-6 levels in patients with shockable cardiac arrest receiving...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_07f10c0ad6324a4bb256b3d1721c6107

Impact of rewarming rate on interleukin-6 levels in patients with shockable cardiac arrest receiving targeted temperature management at 33 °C: the ISOCRATE pilot randomized controlled trial

About this item

Full title

Impact of rewarming rate on interleukin-6 levels in patients with shockable cardiac arrest receiving targeted temperature management at 33 °C: the ISOCRATE pilot randomized controlled trial

Publisher

England: BioMed Central Ltd

Journal title

Critical care (London, England), 2021-12, Vol.25 (1), p.434-434, Article 434

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

While targeted temperature management (TTM) has been recommended in patients with shockable cardiac arrest (CA) and suggested in patients with non-shockable rhythms, few data exist regarding the impact of the rewarming rate on systemic inflammation. We compared serum levels of the proinflammatory cytokine interleukin-6 (IL6) measured with two rewar...

Alternative Titles

Full title

Impact of rewarming rate on interleukin-6 levels in patients with shockable cardiac arrest receiving targeted temperature management at 33 °C: the ISOCRATE pilot randomized controlled trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_07f10c0ad6324a4bb256b3d1721c6107

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_07f10c0ad6324a4bb256b3d1721c6107

Other Identifiers

ISSN

1364-8535

E-ISSN

1364-8535,1466-609X,1366-609X

DOI

10.1186/s13054-021-03842-9

How to access this item